NEW YORK (GenomeWeb) — Tataa Biocenter has signed a deal to distribute and support Yikon Genomics' MALBAC single-cell whole-genome amplification products in Sweden, Norway, Germany, Austria, Slovakia , and the Czech Republic, the partners announced today.
As part of the arrangement, Gothenburg, Sweden-based Tataa will also use the MALBAC technology in its next-generation sequencing training courses. Additional terms were not disclosed.
MALBAC, short for multiple annealing and looping-based amplification cycles, is designed to improve on the amount of genome that can be covered in whole genome amplification methods while also reducing amplification bias. It was developed by Harvard University's Sunney Xie.
"We pioneered single cell transcriptomics over ten years ago and have the broadest product and services offerings in the field in Europe," Tataa CEO Mikael Kubista said in a statement. "Yikon's MALBAC technology … is a perfect complement to our current portfolio allowing us to offer also the best technology for single-cell genomics."